SQ-67563

N/A

Report date: 2026/01/06 18:01:15
NME

Base Information

Drug NameSQ-67563
Drug Alias Name1H-Pyrazolo[3,4-b]pyridine 3SQ-67563
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 1 inhibitorsCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 1Cyclin-dependent kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A